Notably, the transcript levels of S100A8 and S100A9 were found to be significantly up-regulated in GBM tumors as compared to lower grade glioma and control brain tissue in multiple datasets and our cohort (Fig. 4A,B). The gene discussed is S100A8; the disease is central nervous system cancer.